Russell Frank Company’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Russell Frank Company’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-107,104	Closed	-$679K	–	3114
2015 Q4	$679K	Buy	107,104 +103,500	+2,872%	+$679K	﹤0.01%	2381
2015 Q3	$21K	Sell	3,604 -1,802	-33%	-$13.9K	﹤0.01%	2962
2015 Q2	$45K	Buy	5,406 +3,604	+200%	+$31.9K	﹤0.01%	2968
2015 Q1	$15K	Hold	1,802	–	–	﹤0.01%	2924
2014 Q4	$12K	Hold	1,802	–	–	﹤0.01%	2913
2014 Q3	$10K	Buy	+1,802	New	+$10.5K	﹤0.01%	2823
2014 Q2	–	Sell	-1,022	Closed	-$7K	–	2919
2014 Q1	$7K	Buy	+1,022	New	+$7.96K	﹤0.01%	2802
2013 Q4	–	Sell	-40,004	Closed	-$736K	–	3282
2013 Q3	$736K	Buy	40,004 +2,314	+6%	+$44.9K	﹤0.01%	2327
2013 Q2	$660K	Buy	+37,690	New	+$668K	﹤0.01%	2230

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Russell Frank Company's ARIA Position: Q1 2016 in Review

Russell Frank Company sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2016, closing a stake of 107,104 shares — an estimated $679K sold.

Russell Frank Company first reported a position in ARIA in Q2 2013 and held it in 9 quarters. The position peaked at $736K in Q3 2013. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

Russell Frank Company reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
Russell Frank Company sold 107,104 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $679K.
Russell Frank Company first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 9 quarters.
Russell Frank Company's Ariad Pharmaceuticals Inc position peaked at $736K in Q3 2013.
162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.